Defence Therapeutics Inc. (DTC) — Tangible Net Worth Ratio
Defence Therapeutics Inc. (DTC) has a Tangible Net Worth Ratio of 100.0% as of June 2023. This metric is calculated by deducting intangible assets (€0.00) from net assets (€1.57 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore DTC net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Defence Therapeutics Inc. Tangible Net Worth Ratio (2020–2023)
This chart shows how Defence Therapeutics Inc.'s Tangible Net Worth Ratio has changed across 3 annual periods from 2020 to 2023. As of June 2023, the ratio stands at 100.0%, reflecting net assets of €1.57 Million with intangible assets of €0.00 EUR. For live market cap and overall valuation, see market value of Defence Therapeutics Inc..
Annual Tangible Net Worth Ratio for Defence Therapeutics Inc. (2020–2023)
The table below presents the year-by-year Tangible Net Worth Ratio for Defence Therapeutics Inc. from 2020 to 2023, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See Defence Therapeutics Inc. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 97.5% | €1.57 Million | €38.78K | €3.53 Million | ▼ -1.6 pp |
| 2021 | 99.2% | €5.49 Million | €46.02K | €5.61 Million | ▲ +1.6 pp |
| 2020 | 97.5% | €1.86 Million | €46.02K | €1.91 Million | — |